Medical Aesthetic Devices Market to Grow Nearly 10.7% Through 2030

Medical Aesthetic Devices
Spread the love

A report from Precedence Research projects the medical aesthetic devices market size will reach US$ 38.91 billion by 2030, up from US$16.7 billion in 2022.

An increase in demand for minimally invasive procedures, surging prevalence of congenital teeth, rising incidences of face deformities, technological advancements in aesthetic devices, and a rise in the number of cosmetic surgeries are the prominent factors that are boosting the global aesthetic devices market growth. The report contains 150+ pages of detailed analysis. The base year for the study has been considered 2021, the historic year 2017 and 2020, and the forecast period considered is from 2022 to 2030.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1773

Some of the key players in the global medical aesthetic devices market include:

  • Allergan plc
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • LUMENIS LTD
  • MERZ PHARMA GMBH & CO. KGAA
  • Hologic, Inc.
  • Sientra Inc
  • SYNERON MEDICAL LTD
  • VALEANT PHARMACEUTICAL INTERNATIONAL, INC
  • Zimmer Biomet Holdings, Inc.

Covid-19 Scenario-

  • The global economic recession, decline in product demand, and temporary closure of most of the beauty centers affected the medical aesthetic devices market, especially during the initial phase of the pandemic.
  • However, the market is anticipated to recoup really soon.

Report Scope of the Medical Aesthetic Devices Market

Report Coverage Details
Market Size by 2030 USD 38.91 Billion
Growth Rate from 2022 to 2030 CAGR of 10.7%
Largest Market North America
Fastest Growing Region Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Type, Application, End User, Region

The surgical segment to dominate by 2030

By application, the surgical segment contributed to the lion’s share in 2021, holding more than two-thirds of the global medical aesthetic devices market. This is attributed to the fact that surgical medical aesthetic procedures are more accessible and affordable when compared with non-surgical measures. However, the non-surgical segment is projected to manifest the fastest CAGR of more than 11% from 2022 to 2030.

Market Segmentation

By Type

  • Devices
    • Energy-based Aesthetic Device
      • Laser-based Aesthetic Device
      • Radiofrequency (RF)-based Aesthetic Device
      • Light-based Aesthetic Device
      • Ultrasound Aesthetic Device
    • Non-energy-based Aesthetic Device
      • Botulinum Toxin
      • Dermal Fillers and Aesthetic Threads
      • Microdermabrasion
      • Other
  • Aesthetic Implants
    • Facial Implants
    • Breast Implants
    • Others

By Application

  • Surgical
  • Non Surgical

By End User

  • Hospitals and Clinics
  • Medical Spas and Beauty Centers

North America held the major share in 2021

By region, North America dominated in 2021, garnering nearly two-fifths of the global medical aesthetic devices market, owing to increased adoption of medial aesthetics, enhanced technological advancements, and development of novel products by the key players in the province. The market across Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of more than 11% throughout the forecast period. Improvement in R&D facilities, an increase in medical tourism, and a rise in awareness about medical aesthetics drive the market growth in the region.

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Research Methodology

A unique research methodology has been utilized to conduct comprehensive research on the growth of the global medical aesthetic devices market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global medical aesthetic devices market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimate the future prospects of the global market more reliable and accurate.

Why should you invest in this report?

If you are aiming to enter the global medical aesthetic devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for medical aesthetic devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Aesthetic Devices Market

5.1. COVID-19 Landscape: Medical Aesthetic Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Aesthetic Devices Market, By Type

8.1. Medical Aesthetic Devices Market, by Type, 2022-2030

8.1.1 Devices

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Aesthetic Implants

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Medical Aesthetic Devices Market, By Application

9.1. Medical Aesthetic Devices Market, by Application, 2022-2030

9.1.1. Surgical

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Non Surgical

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Medical Aesthetic Devices Market, By End User

10.1. Medical Aesthetic Devices Market, by End User, 2022-2030

10.1.1. Hospitals and Clinics

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Medical Spas and Beauty Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Medical Aesthetic Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2017-2030)

Chapter 12. Company Profiles

12.1. Allergan plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. DentsplySirona Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Johnson & Johnson

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. LUMENIS LTD

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. MERZ PHARMA GMBH & CO. KGAA

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Hologic, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. SientraInc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. SYNERON MEDICAL LTD

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. VALEANT PHARMACEUTICAL INTERNATIONAL, INC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Zimmer Biomet Holdings, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1773

Contact Us:

Precedence Research

Call: +1 9197 992 333

Email: [email protected]

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →